Annual report pursuant to Section 13 and 15(d)

Net Loss per Share - Schedule of Anti-Dilutive Securities Excluded From Computation of Diluted Loss Per Share (Details)

v3.24.0.1
Net Loss per Share - Schedule of Anti-Dilutive Securities Excluded From Computation of Diluted Loss Per Share (Details) - shares
 12 Months Ended
Dec. 31, 2023
Jan. 01, 2023
Jan. 02, 2022
Stock options outstanding      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities (in shares) 2,615,199 5,034,282 5,753,005
Restricted stock units and performance restricted stock units outstanding      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities (in shares) 11,424,740 7,371,158 535,449
Private Placement Warrants outstanding      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities (in shares) 0 0 6,000,000
Public Warrants outstanding      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities (in shares) 0 0 4,322,106
Employee stock purchase plan estimated shares      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities (in shares) 442,146 349,988 47,379
Assumed conversion of Convertible Senior Notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities (in shares) 11,053,800 0 0